Active Pharmaceutical Ingredients Market to Grow by USD 97.6 Billion (2025-2029), Advancing API Manufacturing in Developing Regions Boosts Revenue, AI-Powered Insights – Technavio | PR Newswire [Video]

NEW YORK, Jan. 3, 2025 /PRNewswire/ — Report on how AI is driving market transformation – The global active pharmaceutical ingredients market  size is estimated to grow by USD 97.6 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of over 7.1%  during the forecast period. Evolving api manufacturing scenario in developing scenario is driving market growth, with a trend towards paradigm shift in API manufacturing. However, high investment cost and concern of huge loss  poses a challenge. Key market players include AbbVie Inc., Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cambrex Corp., Cipla Inc., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Indena S.p.A., INTERNATIONAL CHEMICAL INVESTORS S.E., Koninklijke DSM NV, Lupin Ltd., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., Viatris Inc, Sandoz International GmbH (Novartis AG); Fresenius Kabi AG; STADA Arzneimittel AG

AI-Powered Market …